The impact of progressive chronic kidney disease on hepatic drug metabolism.

Saved in:
Bibliographic Details
Title: The impact of progressive chronic kidney disease on hepatic drug metabolism.
Authors: Hartjes ED; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Lim YJ; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Velenosi TJ; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Al KF; Department of Microbiology & Immunology, Western University, London, Ontario, Canada; Canadian Centre for Human Microbiome and Probiotics, London, Ontario, Canada., Macklaim JM; Department of Microbiology & Immunology, Western University, London, Ontario, Canada., Kucey AS; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Reid G; Department of Microbiology & Immunology, Western University, London, Ontario, Canada; Canadian Centre for Human Microbiome and Probiotics, London, Ontario, Canada., Burton JP; Department of Microbiology & Immunology, Western University, London, Ontario, Canada; Canadian Centre for Human Microbiome and Probiotics, London, Ontario, Canada., Gloor GB; Department of Biochemistry, University of Western Ontario, London, Ontario, Canada., Urquhart BL; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; Division of Nephrology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: Brad.Urquhart@schulich.uwo.ca.
Source: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2025 Jun; Vol. 53 (6), pp. 100085. Date of Electronic Publication: 2025 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-009X
DOI:10.1016/j.dmd.2025.100085